Human papillomavirus detection and typification in cutaneous and mucosal lesions of HIV-seropositive patients

International Journal of STD and AIDS

Volumn 19, Issue 9, 2008, Pages 611-616

  Nunes, Mariana De Gusmão ^a,c   Azevedo e Silva, Melissa ^a   Gonçalves, Carolina Pereira ^a   Trope, Beatriz Moritz ^a   Oliveira, Ledy Do Horto Dos Santos ^b   Ramos e Silva, Marcia ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c NONE   (Brazil)

Author keywords

HIV; Homosexual; HPV; South America

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURAL FACTOR; DISEASE SEVERITY; DYSPLASIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MALE; MUCOSAL DISEASE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SKIN DEFECT; SOCIOECONOMICS; VIRUS DETECTION; VIRUS TYPING; WART VIRUS;

ADULT; CROSS-SECTIONAL STUDIES; DNA, VIRAL; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; WARTS;

EID: 50849101680     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2007.007224     Document Type: Article

References (42)

1. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997;102:3-8
2. Severson JL. Viral Disease Update. Current Problems in Dermatology. St. Louis 1999;11:37-72
3. Villa LL, Costa RL, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) L1 virus-like particle vaccine in young human: a randomized double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005;6:271-8
4. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189(1):12-9
5. Villa LL, Bernard H-U, Kast M, Hildesheim A, Amestoy G, Franco EL. Past, present, and future of HPV research: highlights from the 19th International Papillomavirus Conference - HPV2001. Virus Res 2002;89:163-73
6. Brenna SM, Syrjanen KJ. Regulation of cell cycles is of key importance in human papillomavirus (HPV)-associated cervical carcinogenesis. São Paulo Med J 2003;121:128-32
7. Grussendorf-Conen E-I. Anogenital premalignant and malignant tumors (including Buschke-Löwenstein tumors). Clin Dermatol 1997;15:377-88
8. Gomousa-Michael M, Gialama E, Gomousas N, Gialama G. Genital human papillomavirus infection and associated penile intraepithelial neoplasia in males infected with human immunodeficiency virus. Acta Cytol 2000;44:305-9
9. De Sanjosé S, Palefsky J. Cervical and anal HPV infections in HIV positive women and men. Virus Res 2002;89:201-11
10. McKaig RG, Baric RS, Olshan AF. Human papillomavirus and head and neck cancer: epidemiology and molecular biology. Head Neck 1998;20:250-65
11. Lowy DR, Howley PM. Papillomavirus. In: Knipe DM, Howley PM, Griffin DE eds. Fields Virology. 4th edn. Philadelphia: Lippincott Williams & Wilkins, 2001
12. Ellerbrock TV, Chiasson MA, Bush TJ, et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 2000;283:1031-7
13. Palefsky JM, Holly E A, Ralston ML, Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis 1998;177:361-7
14. Palefsky JM, Holly EA, Ralston ML, et al. Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men: prevalence and risk factors. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:320-6
15. Schecter WP. Human immunodeficiency virus and malignancy: thoughts on viral oncogenesis. Arch Surg 2001;136:1419-25
16. Bouwes Bavinck JN, Berkhout RJ. HPV infections and immunosuppression. Clin Dermatol 1997;15:427-37
17. Aynaud O, Piron D, Barrasso R, Poveda JD. Comparison of clinical, histological and virological symptoms of HPV in HIV-1 infected men and immunocompetent subjects. Sex Transm Infect 1998;74:32-4
18. Cubie HA, Seagar AL, Beattie GJ, Monaghan S, Williams AR. A longitudinal study of HPV detection and cervical pathology in HIV infected women. Sex Transm Inf 2000;76:257-61
19. Bryan JT, Stoler MH, Tyring SK, McClowry T, Fife KH, Brown DR. High-grade dysplasia in genital warts from two patients infected with the human immunodeficiency virus. J Med Virol 1998;54:69-73
20. Wikström A. Clinical and serological manifestations of genital human papillomavirus infection. Acta Derm-Venereol 1995;193:1-85
21. Heard I, Schmitz V, Costagliola D, Orth G, Kazatchkine MD. Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy. AIDS 1998;12:1459-64
22. Kiviat NB, Critchlow CW, Holmes KK, et al. Association of anal dysplasia and human papillomavirus with immunosuppression and HIV infection among homosexual men. AIDS 1993;7:43-9
23. Piketty C, Darragh TM, Da Costa M, et al. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med 2003;138:453-9
24. Palefsky JM, Holly EA, Ralston ML, et al. Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection. J Acquir Immune Defic Syndr 2001;28:422-8
25. Rudlinger R, Buchmann P. HPV 16-positive bowenoid papulosis squamous-cell carcinoma of the anus in an HIV-positive man. Dis Colon Rectum 1989;32(12):1042-5
26. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 1989;7:209-14
27. Barzegar C, Paul C, Saiag P, et al. Epidermodysplasia verruciformis-like eruption complicating human immunodeficiency virus infection. Br J Dermatol 1998;139:122-7
28. Trauner MA, Ruben BS, Hatcher SL, Lawry MA. Groin eruption in an HIV-positive man. Arch Dermatol 2002;138(4):527-32.
29. Carré D, Dompmartin A, Verneuil L, et al. Epidermodysplasia verruciformis in a patient with HIV infection: no response to highly active antiretroviral therapy. Int J Dermatol 2003;42:296-300
30. Surentheran T, Harwood CA, Spink PJ, et al. Detection and typing of human papillomaviruses in mucosal and cutaneous biopsies from immunosuppressed and immunocompetent patients and patients with epidermodysplasia verruciformis: a unified diagnostic approach. J Clin Pathol 1998;51:606-10
31. Carestiato FN. Análise comparativa de técnicas de biologia molecular para o diagnóstico de infecções causadas por papilomav?́rus humanos no colo de útero. MS Thesis. Niteró i, Brazil. Curso de Pós-graduação em Patologia Experimental, Fluminense Federal University, 2005
32. Rolighed J, Sorensen IM, Jacobsen NO, Lindeberg H. The presence of HPV types 6/11, 13, 16 and 33 in bowenoid papulosis in an HIV-positive male, demonstrated by DNA in situ hybridization. APMIS 1991;99:583-5
33. Park KC, Kim KH, Youn SW, et al. Heterogeneity of human papillomavirus DNA in a patient with Bowenoid papulosis that progressed to squamous cell carcinoma. Br J Dermatol 1998;139:1087-91
34. Nunes MG, Trope BM, Cavalcanti SMB, Oliveira LHS, Ramos-e-Silva M. Bowenoid papulosis in a patient with AIDS treated with imiquimod: case report. Acta Dermatovenerol Croat 2004;12:278-81
35. Neves D, Camara GNL, Alencar TR, Da Cruz MR, Martins CRF, Carvalho LGS. Prevalence of human papillomavirus in penile carcinoma. Braz J Urol 2002;28:221-6
36. França FB. Carcinoma epidermóide do pênis: estudo de 34 casos no HUCFF/UFRJ. Tese de mestrado. Universidade Federal do Rio de Janeiro, Rio de Janeiro, 2005
37. Praetorius F. HPV-associated diseases of oral mucosa. Clin Dermatol 1997;15:399-413
38. Soler C, Chardonnet Y, Allibert P, Euvrard S, Schmitt D, Mandrand B. Detection of mucosal human papillomavirus types 6/11 in cutaneous lesions from transplant recipients. J Invest Dermatol 1993;101:286-91
39. Cavalcanti SM, Deus FC, Oliveira LH. Unusual HPV types in cutaneous warts in association with immunological deficiency. Mem Inst Oswaldo Cruz 1998;93:433-4
40. Porro AM, Alchorne MM, Mota GR, Michalany N, Pignatari AC, Souza IE. Detection and typing of human papillomavirus in cutaneous warts of patients infected with human immunodeficiency virus type 1. Br J Dermatol 2003;149:1192-9
41. Holly EA, Ralston ML, Darragh TM, Greenblatt RM, Jay N, Palesky JM. Prevalence and risk factors for anal squamous intraepithelial lesions in women. J Natl Cancer Inst 2001;93:843-9
42. Lillo F, Ferrari D, Veglia F, et al. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy. J Infect Dis 2001;184:547-51